Senators reach tentative deal on $10 billion in additional Covid funding, Romney says

Senators reach tentative deal on  billion in additional Covid funding, Romney says


U.S. Senator Mitt Romney (R-UT) walks through the Senate Subway on his way to a security briefing for senators on Russia’s invasion of Ukraine, on Capitol Hill in Washington, March 30, 2022.

Elizabeth Frantz | Reuters

Senate Republicans and Democrats have reached a tentative deal on $10 billion in additional Covid funding, less than half the sum that President Joe Biden had requested to shore up the nation’s pandemic response ahead of another potential infection wave.

Sen. Mitt Romney, R-Utah, told reporters he had a deal with Senate Majority Leader Chuck Schumer, D-NY, to cover the spending by redirecting money from the American Rescue Plan passed last year. The funding is far less than $22.5 billion the White House had requested from Congress.

Biden warned yesterday that the U.S. would not have enough Covid vaccine doses for all Americans this fall if Congress failed to act. The White House has also warned the uninsured would no longer have coverage for Covid testing, treatments and vaccinations. The U.S. would also face shortages of monoclonal antibody treatments, antiviral pills and Covid testing, according to administration officials.

It is not clear what the package would cover, as senators have not yet released details. The text of the agreement, when finished, would go the Congressional Budget Office to show that the funding is balanced by offsets.

House Democrats originally sought to pass $15 billion in Covid money earlier this month as part of a larger government funding package. However, House Speaker Nancy Pelosi pulled the Covid funding after Republicans and Democrats failed to agree on how to pay for it.

The GOP insisted on covering any new spending by clawing back money already appropriated for state and local governments, but Democrats rejected that demand.

A more contagious variant of omicron, BA.2, is spreading in the U.S. It now makes more than half of all infections that have undergone genetic sequencing, according to the Centers for Disease Control and Prevention. BA.2 has caused new Covid outbreaks in Europe and China, raising concerns the subvariant could do the same in the U.S.

White House chief medical advisor Dr. Anthony Fauci said earlier this month that BA.2 will likely cause an increase of infections in the U.S., though he doesn’t expect another surge. Epidemiologists say the U.S. could face another wave in the fall, as immunity from the vaccines wanes and people move indoors due to the colder weather.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Health

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]

Read More
Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula
Health

Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula

Laura Modi, co-founder and CEO of infant formula startup Bobbie, is on a mission to transform an industry that she says has been stagnant for decades, and shift the culture around how parents feed their babies. Modi, a former Airbnb executive, came up with the idea for Bobbie after the birth of her first child. […]

Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More